However, due to the activation of the RIG-I signaling pathway, isiBCL-2 exhibits a more pronounced effectiveness in impeding tumor cell proliferation and promoting apoptosis in both in vitro and in vivo contexts. This evidence concerns the gene RIGI and neoplasm.